The effect of zoledronic acid and denosumab on the mandible and other bones: a 18F-NaF-PET study

ConclusionsThe remodeling of mandible was not suppressed due to the treatment with anti-resorptive agents. Differences in the mechanisms of action between the BP and Dmab caused the specificity of the effect on the metabolism of normal bone.

http://link.springer.com/10.1007/s11282-022-00594-2

Source: Oral Radiology - February 10, 2022 Category: Radiology Source Type: research